Skip to main content

and
  1. Article

    Open Access

    Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma

    Gene-modified autologous T cells expressing NY-ESO-1c259, an affinity-enhanced T-cell receptor (TCR) reactive against the NY-ESO-1-specific HLA-A*02-restricted peptide SLLMWITQC (NY-ESO-1 SPEAR T-cells; GSK 794),...

    Indu Ramachandran, Daniel E. Lowther in Journal for ImmunoTherapy of Cancer (2019)

  2. No Access

    Article

    CAR T cell therapy: inroads to response and resistance

    Here, we highlight key papers published in 2018 that advance our understanding of resistance to chimeric antigen receptor (CAR) T cell immunotherapy for leukaemia and lymphoma and in so doing reveal barriers t...

    Christine E. Brown, Crystal L. Mackall in Nature Reviews Immunology (2019)

  3. Article

    Open Access

    Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

    Chimeric Antigen Receptor (CAR) T cell therapies – adoptive T cell therapies that have been genetically engineered for a new antigen-specificity - have displayed significant success in treating patients with h...

    Michael M. Boyiadzis, Madhav V. Dhodapkar in Journal for ImmunoTherapy of Cancer (2018)

  4. Article

    Chimeric Antigen Receptors for Cancer: Progress and Challenges

    Chimeric antigen receptors (CARs) genetically link an antigen-binding domain with cell-signaling domains to redirect immune cell specificity toward antigens expressed on the surface of cancer cells. Progress i...

    Adrienne H. Long, Daniel W. Lee, Crystal L. Mackall in Current Stem Cell Reports (2015)

  5. Article

    Open Access

    Enhanced glycolytic metabolism is associated with exhaustion and poor antitumor efficacy in a xenograft model of chimeric antigen receptor T cell therapy for sarcoma

    Adrienne H Long, Rimas J Orentas, Crystal L Mackall in Journal for ImmunoTherapy of Cancer (2013)

  6. Article

    Open Access

    ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors

    Rimas J Orentas, Paola Lopomo, William Babbitt in Journal for ImmunoTherapy of Cancer (2013)

  7. Article

    Open Access

    Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors

    Steven L Highfill, Adrienne H Long, Rimas J Orentas in Journal for ImmunoTherapy of Cancer (2013)

  8. No Access

    Article

    Harnessing the biology of IL-7 for therapeutic application

  9. Interleukin-7 (IL-7) is required for T cell development in mice and humans and is produced by stromal tissues rather than activated lymphocytes. Under normal c...

  10. Crystal L. Mackall, Terry J. Fry, Ronald E. Gress in Nature Reviews Immunology (2011)

  11. Article

    Reply to “Is IL-7 from dendritic cells essential for the homeostasis of CD4+ T cells?”

    Crystal L Mackall, Martin Guimond in Nature Immunology (2010)

  12. No Access

    Article

    Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches

    Dendritic cells (DCs) serve as central regulators of adaptive immunity by presenting antigens and providing necessary co-signals. Environmental information received by the DCs determines the co-signals deliver...

    Terry J. Fry, Jessica L. Shand, Matthew Milliron in Cancer Immunology, Immunotherapy (2009)

  13. No Access

    Article

    Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells

    Compared with naive CD8+ T cells, naive CD4+ T cells undergo inefficient homeostatic proliferation. Mackall and colleagues now attribute this difference to interleukin 7–mediated suppression of the expression of ...

    Martin Guimond, Rachelle G Veenstra, David J Grindler, Hua Zhang in Nature Immunology (2009)

  14. No Access

    Article

    Immune reconstitution prevents metastatic recurrence of murine osteosarcoma

    Primary tumors develo** in immunocompetent hosts escape immunosurveillance by acquiring immune evasive properties. This raises the prospect that metastases derived from such tumors will also evade immunity. ...

    Melinda S. Merchant, Fraia Melchionda, Manoj Sinha in Cancer Immunology, Immunotherapy (2007)

  15. No Access

    Article

    Current concepts of thymic aging

    Terry J. Fry, Crystal L. Mackall in Springer Seminars in Immunopathology (2002)

  16. No Access

    Chapter

    Langerhans Cells in the TGFβ1 Null Mouse

    We recently identified a cell surface protein (gp40) that is homologous to human Ep­CAM, a putative homophilic adhesion molecule, and that is abundantly expressed by some murine dendritic cells (including Lang...

    Teresa A. Borkowski, John J. Letterio in Dendritic Cells in Fundamental and Clinica… (1997)